-Clifford Hudis Researcher Activity Profile

Research Author Detailed Information 

Clifford Hudis Publication Rate By Year

Clifford Hudis has published 1 paper(s) in 1999, 1 paper(s) in 2006, 13 paper(s) in 2007, 4 paper(s) in 2008, for a total of 19 research publications in total.

Clifford C Hudis Author Information

LAST NAME: hudis

FIRST NAME: Clifford

INITIALS: c

AFFILIATION:

Papers

Clifford Hudis's Publication Record

1. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Year Published: 2006
Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. hurriaa@mskcc.org
2. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Year Published: 2007
Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. ahurria@coh.org
3. Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21. Year Published: 2007
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. gilewskt@mskcc.org
4. Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors. Year Published: 2007
Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
5. Current status of the taxanes as adjuvant therapy for breast cancer. Year Published: 2007
Solid Tumor Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, MSKCC, 1275 York Avenue, New York, NY, USA.
6. Preoperative chemotherapy for breast cancer: miracle or mirage? Year Published: 2007
Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill College of Medicine, Cornell University, New York, New York 10024, USA. hudisc@mskcc.org
7. Preoperative chemotherapy for breast cancer: miracle or mirage? Year Published: 2007
Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill College of Medicine, Cornell University, New York, New York 10024, USA. hudisc@mskcc.org
8. Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II-III Breast Cancer: Treatment Intervals and Clinical Outcomes. Year Published: 2007
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.
9. Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors. Year Published: 2007
Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
10. Current status of the taxanes as adjuvant therapy for breast cancer. Year Published: 2007
Solid Tumor Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, MSKCC, 1275 York Avenue, New York, NY, USA. hudisc@mskcc.org
11. Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes. Year Published: 2007
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
12. EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells: EVIDENCE OF A BRCA1 AND p300 EXCHANGE. Year Published: 2008
Department of Medicine, Weill Cornell Medical College, New York, New York 10065.
13. Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes. Year Published: 2007
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
14. Complete percutaneous excision of infiltrating carcinoma at stereotactic breast biopsy: how can tumor size be assessed? Year Published: 1999
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
15. Current status of the taxanes as adjuvant therapy for breast cancer. Year Published: 2007
Solid Tumor Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, MSKCC, 1275 York Avenue, New York, NY, USA. hudisc@mskcc.org
16. Preoperative chemotherapy for breast cancer: miracle or mirage? Year Published: 2007
Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill College of Medicine, Cornell University, New York, New York 10024, USA. hudisc@mskcc.org
17. EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange. Year Published: 2008
Department of Medicine, Weill Cornell Medical College, New York, New York 10065, USA. ksubba@me.cornell.edu
18. Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840. Year Published: 2008
Corresponding author: Andrew D. Seidman, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; e-mail: seidmana@mskcc.org.
19. Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840. Year Published: 2008
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. seidmana@mskcc.org